AI-Powered Solutions Aim to Prevent 80% of Cardiovascular Deaths
Cardio Diagnostics Holdings (CDIO) uses AI, epigenetics, and genetics to prevent cardiovascular disease. Learn how their Epi+Gen CHD and PrecisionCHD solutions aim to reduce CVD deaths.
This news matters because it highlights a shift toward proactive, personalized cardiovascular care using AI and epigenetics. For readers, the potential to prevent up to 80% of CVD cases means that earlier detection and tailored interventions could save lives, reduce healthcare burdens, and empower individuals with actionable insights about their heart health.